FRANKLINTON, N.C.--(BUSINESS WIRE)--On Friday, a federal court in Delaware ordered Danisco to pay damages of USD 4,088,584 plus prejudgment interest for infringing Novozymes’ (PINK SHEETS:NVZMF) U.S. Patent No. 6,867,031 covering Spezyme® Ethyl, an enzyme used to manufacture bioethanol. The federal court also found that Danisco willfully infringed Novozymes’ patent and that the case was exceptional. As a result, the court doubled the damages and also awarded Novozymes attorneys’ fees and costs.
